American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

 

Brian Anderson
Vice President & Assistant General Counsel
IP Litigation
Allergan
Debra-Condino
Debra Condino
Vice President, Intellectual Property
Sienna Biopharmaceuticals (Westlake Village, CA)

 

Guy-Donatiello
Guy Donatiello
Senior Vice President, Intellectual Property
Endo Pharmaceuticals (Malvern, PA)
Rekha Hanu, Ph.D, J.D
Executive Director, Chief IP Counsel
Akorn Pharmaceuticals (Lake Forest, IL)

 

brian_hirsch

Brian Hirsch
Vice President Global IP and Legal Head North America
Glenmark Pharmaceuticals (Mahwah, NJ)

amy-hulina
Amy Hulina
SVP, Intellectual Property
Amneal Pharmaceuticals

 

Lisa-Jakob
Lisa A. Jakob
Legal Director, IP Litigation
Merck & Company (Rahway, NJ)
staci_julie
Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)

 

James Kellerman
Vice President, Intellectual Property
Astellas Pharma US, Inc. (Northbrook, IL)
James-Leeds
James P. Leeds
Assistant General Patent Counsel
Eli Lilly & Company (Indianapolis, IN)

 

staci_julie
Josephine Liu, Ph.D., J.D.
Head, US IP Litigation
Sandoz Inc. (Princeton, NJ)
Jennifer Grant Moitoso
Vice President, Intellectual Property
Shire

 

Jeffrey-Myers

Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel
Pfizer Inc (New York, NY)

Mark-Rachlin
Mark Rachlin
Senior Patent Counsel-Litigation
GlaxoSmithKline (King of Prussia, PA)

 

Carmen-Shepard
Carmen M. Shepard
Senior Vice President,
Global Policy and Regulatory Counsel
Mylan (Washington, DC)
Pearl-Siew
Pearl T. L. Siew
Senior Vice President and Head Intellectual Property
Eagle Pharmaceuticals, Inc (Woodcliff Lake, NJ)

 

Meg-Snowden
Meg Snowden
VP, Intellectual Property
Impax Laboratories (Hayward, CA)
Peter-Waibel
Peter Waibel
Head, US Patent Litigation
Novartis Pharmaceuticals Corporation (East Hanover, NJ)

 

Stephanie Donahue
Senior Director, Patent Litigation
Sanofi

 
 

Emeritus Members:

 

Stephen-Auten
Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP (Chicago, IL)
(Former Vice President, IP, Sandoz, Inc.)
George-Johnston
George W. Johnston
Counsel,
Gibbons P.C. (Newark, NJ)
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)

 

David-Silverstein
David H. Silverstein, M.S., J.D.
Partner
Axinn, Veltrop & Harkrider LLP (New York, NY)
(Former Senior Director, Intellectual Property, Par Pharmaceutical, Inc)
Shashank-Upadhye
Shashank Upadhye
Partner
Amin Talati & Upadhye (Chicago, IL)
(Former Vice President – Global Intellectual Property, Apotex, Inc.)